| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 650,400 | 647,800 | 647,100 | 691,769 | | Cost of Revenue | (91,400) | 44,900 | 46,500 | (120,576) | | | Gross Profit | 741,800 | 602,900 | 600,600 | 812,345 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 276,800 | 142,100 | 146,700 | 321,720 | | Non Recurring | 23,000 | 1,400 | 3,200 | 2,774 | | Others | 63,000 | 60,600 | 64,300 | 69,996 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 401,400 | 398,800 | 386,400 | 417,855 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (119,700) | 10,100 | 4,200 | (216,430) | | Earnings Before Interest And Taxes | 387,800 | 407,200 | 389,400 | 197,796 | | Interest Expense | 32,000 | 32,300 | 38,900 | 86,633 | | Income Before Tax | 355,800 | 374,900 | 350,500 | 111,163 | | Income Tax Expense | 153,500 | 153,100 | 151,400 | 49,098 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 197,800 | 221,800 | 199,100 | 62,065 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 202,300 | 221,800 | 199,100 | 62,065 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $202,300 | $221,800 | $199,100 | $62,065 |
|
0.01% Nasdaq 
0.22%
Income Statement
